Literature DB >> 23903266

SAPS 3, APACHE IV or GRACE: which score to choose for acute coronary syndrome patients in intensive care units?

Antonio Paulo Nassar Junior1, Amilcar Oshiro Mocelin, Fabio Moreira Andrade, Leonardo Brauer, Fabio Poianas Giannini, Andre Luiz Baptiston Nunes, Carlos Augusto Dias.   

Abstract

CONTEXT AND OBJECTIVE Acute coronary syndromes (ACS) are a common cause of intensive care unit (ICU) admission. Specific prognostic scores have been developed and validated for ACS patients and, among them, GRACE (Global Registry of Acute Coronary Events) has had the best performance. However, intensive care clinicians generally use prognostic scores developed from heterogeneous populations of critically ill patients, such as APACHE IV (Acute Physiologic and Chronic Health Evaluation IV) and SAPS 3 (Simplified Acute Physiology Score 3). The aim of this study was to evaluate and compare the performance of these three scores in a non-selected population of ACS cases. DESIGN AND SETTING Retrospective observational study to evaluate three prognostic scores in a population of ACS patients admitted to three general ICUs in private hospitals in São Paulo. METHODS All patients with ACS admitted from July 2008 to December 2009 were considered for inclusion in the study. Score calibration and discrimination were evaluated in relation to predicting hospital mortality. RESULTS A total of 1065 patients were included. The calibration was appropriate for APACHE IV and GRACE but not for SAPS 3. The discrimination was very good for all scores (area under curve of 0.862 for GRACE, 0.860 for APACHE IV and 0.804 for SAPS 3). CONCLUSIONS In this population of ACS patients admitted to ICUs, GRACE and APACHE IV were adequately calibrated, but SAPS 3 was not. All three scores had very good discrimination. GRACE and APACHE IV may be used for predicting mortality risk among ACS patients.

Entities:  

Mesh:

Year:  2013        PMID: 23903266     DOI: 10.1590/1516-3180.2013.1313474

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  5 in total

1.  Validation of the APACHE IV model and its comparison with the APACHE II, SAPS 3, and Korean SAPS 3 models for the prediction of hospital mortality in a Korean surgical intensive care unit.

Authors:  Hannah Lee; Yoon-Jung Shon; Hyerim Kim; Hyesun Paik; Hee-Pyoung Park
Journal:  Korean J Anesthesiol       Date:  2014-08-26

Review 2.  Evaluation of Simplified Acute Physiology Score 3 performance: a systematic review of external validation studies.

Authors:  Antonio Paulo Nassar; Luiz Marcelo Sa Malbouisson; Rui Moreno
Journal:  Crit Care       Date:  2014-06-06       Impact factor: 9.097

3.  External validation of SAPS 3 and MPM0-III scores in 48,816 patients from 72 Brazilian ICUs.

Authors:  Giulliana Martines Moralez; Ligia Sarmet Cunha Farah Rabello; Thiago Costa Lisboa; Mariza da Fonte Andrade Lima; Rodrigo Marques Hatum; Fernando Vinicius Cesar De Marco; Alessandra Alves; Jorge Eduardo da Silva Soares Pinto; Hélia Beatriz Nunes de Araújo; Grazielle Viana Ramos; Aline Reis Silva; Guilherme Côrtes Fernandes; Guilherme Brenande Alves Faria; Ciro Leite Mendes; Roberto Álvaro Ramos Filho; Valdênia Pereira de Souza; Pedro Emmanuel Alvarenga Americano do Brasil; Fernando Augusto Bozza; Jorge Ibrain Figueira Salluh; Marcio Soares
Journal:  Ann Intensive Care       Date:  2017-05-18       Impact factor: 6.925

4.  The Ability of the Acute Physiology and Chronic Health Evaluation (APACHE) IV Score to Predict Mortality in a Single Tertiary Hospital.

Authors:  Jae Woo Choi; Young Sun Park; Young Seok Lee; Yeon Hee Park; Chaeuk Chung; Dong Il Park; In Sun Kwon; Ju Sang Lee; Na Eun Min; Jeong Eun Park; Sang Hoon Yoo; Gyu Rak Chon; Young Hoon Sul; Jae Young Moon
Journal:  Korean J Crit Care Med       Date:  2017-08-31

5.  APACHE IV score in postoperative kidney transplantation.

Authors:  Edison Moraes Rodrigues-Filho; Anderson Garcez
Journal:  Rev Bras Ter Intensiva       Date:  2018 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.